Early State Lung Cancer

Advances in Lung Cancer Evaluation
and Management

Locally Advanced Lung Cancer:
Treatment Approach

Print this Content

 

Release Date:   December 21, 2011
Expiration Date:  December 21, 2013

 

How to Obtain AMA PRA
Category 1 Credit™

  1. Complete the CME case-based lesson (each question must be answered correctly).
  2. Login to your account.
  3. Complete the credit and evaluation form.
  4. Print your personalized CME certificate.

Technical Requirements

  

Estimated Time of Completion:  30 minutes

Description

These case-based lessons provide a clinically based overview of current issues in the multidisciplinary management of patients with lung cancer, with an emphasis on the impact of tumor staging on treatment selection.

Learning Objectives

  1. Identify treatment standards for non-small cell lung cancer (NSCLC) screening, diagnosis, and staging.
  2. List important laboratory tests for assessing a patient's physical condition and discuss the impact of test results on the treatment options.
  3. Discuss treatment options for NSCLC from the viewpoints of radiation oncologists, medical oncologists, and surgeons.
  4. Compare and contrast treatment options for adjuvant chemotherapy using either chemotherapy alone or combined chemoradiation therapy.

Target Audience

This activity is directed to medical oncologists, radiation oncologists, pulmonologists, thoracic surgeons, internists, and nurses.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Directors

Peter Mazzone, MD
Department of Pulmonary, Allergy
   and Critical Care Medicine
Cleveland Clinic
Cleveland, OH

Nathan Pennell, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Faculty

Peter Mazzone, MD
Department of Pulmonary, Allergy
   and Critical Care Medicine
Cleveland Clinic
Cleveland, OH

Nathan Pennell, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Patrick Ma, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Marc Shapiro, MD
Department of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Gregory Videtic, MD
Department of Radiation Oncology
Cleveland Clinic
Cleveland, OH

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of this presentation, could be perceived as a potential conflict of interest:

Peter Mazzone, MD

Boehringer Ingelheim

 Membership on advisory committee or review panels
 
Nathan Pennell, MD

Boehringer Ingelheim

 Membership on advisory committee or review panels

The following faculty have indicated that they have no relationship which, in the context of this presentation, could be perceived as a potential conflict of interest:

Patrick Ma, MD
Marc Shapiro, MD
Gregory Videtic, MD

The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from:

Pfizer
Genentech
Merck

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education,
Respiratory Institute, and Taussig Cancer Institute.

CME Disclaimer